Injective INJ
Current Price
$5.14 -7.64%
$0.4500 Daily Range (8.75%)
$5.13$5.58
$73.19M Daily Volume
769 BTC
Vol/MktCap: 14.19%
Market Performance
0.12% Relative BTC Volume
The total volume of Injective is $73.19M over the past 24 hours, compared to $62.29B total Bitcoin volume.
Hourly Moving Average
8 SMA $5.31 -3.17%
13 SMA $5.33 -3.48%
21 SMA $5.37 -4.33%
55 SMA $5.49 -6.33%
144 SMA $5.30 -2.99%
Price Performance
-1.31% 1 Hour Change
$5.14 from $5.21
-1.02% 7 Day Change
-$0.0523 from $5.19
+16.02% 14 Day Change
$0.8234 from $4.32
+2.91% 30 Day Change
$0.1497 from $4.99
All Time High
March 14, 2024
$52.62 -90.19%
-$47.46 vs. now
24H Change
-41.97M USD -7.53%
-441 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
13.67M INJ
traded over past 24 hours
13.67% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $5.38, experiencing a 24-hour decline of approximately 2.93%. The daily range has been relatively tight, with a high of $5.71 and a low of $5.30, indicating a potential consolidation phase.
The volume stands at around 83.9 million, with a volume-to-market cap ratio of 15.59%, suggesting decent liquidity. However, the current hourly moving averages show mixed signals; while the 8 SMA is slightly positive, the longer-term SMAs (21 and 55) indicate downward pressure, reflecting bearish sentiment in the short term.
The 1-hour RSI is at 37, suggesting the asset is nearing oversold territory, which may attract buyers soon. In contrast, the 7-day RSI at 51 indicates neutral momentum, while the 14-day and 30-day price changes of 26.06% and 8.50% respectively suggest a strong upward trend over the longer term.
Despite the current price decline, the 7-day price change of approximately 6.80% reflects some resilience and potential for recovery. The all-time high of $52.62, reached earlier in 2024, presents a long-term target, but the current price indicates a significant gap that may deter immediate bullish sentiment.
In summary, while INJ is facing short-term bearish indicators, the longer-term trends and relatively high RSI levels suggest a potential for recovery. Therefore, the rating for Injective (INJ) is a Hold, as the current price offers a potential entry point for long-term investors while monitoring for bullish confirmation in the near term.
The volume stands at around 83.9 million, with a volume-to-market cap ratio of 15.59%, suggesting decent liquidity. However, the current hourly moving averages show mixed signals; while the 8 SMA is slightly positive, the longer-term SMAs (21 and 55) indicate downward pressure, reflecting bearish sentiment in the short term.
The 1-hour RSI is at 37, suggesting the asset is nearing oversold territory, which may attract buyers soon. In contrast, the 7-day RSI at 51 indicates neutral momentum, while the 14-day and 30-day price changes of 26.06% and 8.50% respectively suggest a strong upward trend over the longer term.
Despite the current price decline, the 7-day price change of approximately 6.80% reflects some resilience and potential for recovery. The all-time high of $52.62, reached earlier in 2024, presents a long-term target, but the current price indicates a significant gap that may deter immediate bullish sentiment.
In summary, while INJ is facing short-term bearish indicators, the longer-term trends and relatively high RSI levels suggest a potential for recovery. Therefore, the rating for Injective (INJ) is a Hold, as the current price offers a potential entry point for long-term investors while monitoring for bullish confirmation in the near term.
Updated 411 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

X cracks down on ‘InfoFi’ reward models, triggering sell-offs across crypto social tokens
Crypto tokens tied to InfoFi-style reward models fell sharply after X revised its API policies to ban apps that pay users for posting.

Michael Saylor's Strategy still has major upside despite 2025 plunge, says TD Cowen
Strategy remains an effective proxy for bitcoin exposure, particularly for investors with a long-term view, analyst Lance Vitanza said.

These three XRP charts hint at a price rally toward $2.80
XRP’s technical and onchain signals hint at a bullish breakout, with bulls eyeing a significant rally toward $2.80 by the month’s end.

Bitcoin miner IREN tops X’s most-searched cashtags, beating Tesla and Bitcoin
Bitcoin miner IREN ranks first on X’s most searched cashtags.